A hyaluronan scaffold decorated with the natural antimicrobial peptide cathelicidin-BF killed both S. aureus and E. coli, switched macrophages from inflammatory (M1) to healing (M2) phenotype, and accelerated infected wound healing in mice with enhanced collagen deposition.
Dual antibacterial + M1→M2 switchcathelicidin-BF on hyaluronan scaffold kills bacteria first, then promotes tissue healing by driving macrophage phenotype change — addressing both problems of infected wound healing
What the researchers found
Cathelicidin-BF-decorated hyaluronan scaffold (HAG-g-C) provided dual antibacterial and anti-inflammatory function, killing S. aureus and E. coli while driving M1-to-M2 macrophage polarization and accelerating infected wound healing in mice.
Why it matters
Infected wounds are a major clinical challenge, especially with rising antibiotic resistance. A wound dressing that simultaneously kills bacteria AND shifts the immune response from inflammation to healing addresses both problems at once — potentially reducing healing time and antibiotic use for infected wounds.
The numbers in context
Effective against both Staphylococcus aureus and Escherichia coli in vitro. Promoted M1-to-M2 macrophage transition.
How the study worked
Designed HAG-g-C scaffold by cross-linking hyaluronan with gallic acid-modified gelatin and decorating with cathelicidin-BF antimicrobial peptide. Tested antibacterial activity against S. aureus and E. coli in vitro. Assessed macrophage polarization (M1→M2). Evaluated wound healing in S. aureus-infected full-thickness skin defect mouse model over 12 days.
Who was studied
In vitro bacterial cultures and animal wound models
What this study cannot tell us
Mouse model — wound healing differs between mice and humans. Only tested against two bacterial species. Long-term degradation profile of the scaffold not fully characterized. Manufacturing complexity and cost vs. conventional wound dressings not assessed. Single antimicrobial peptide — synergy with additional antimicrobials not explored.
How to read the evidence
Preliminary — animal study with in vitro validation. Demonstrates proof-of-concept for dual-function antimicrobial peptide wound scaffolds, but human wound healing trials needed.
When this study was published
Published in 2024, contributing to the growing field of bioactive wound dressing development using antimicrobial peptides.
The bigger picture
This study exemplifies the trend toward 'smart' wound dressings that do more than passively cover wounds. By combining an antimicrobial peptide with an immune-modulating scaffold, it addresses the two sequential challenges of infected wound healing: first clear the infection, then promote tissue repair. The use of a natural AMP (cathelicidin-BF) rather than a conventional antibiotic reduces resistance concerns.
Questions still open
- How does the scaffold perform against drug-resistant bacteria like MRSA?
- What is the optimal cathelicidin-BF loading for balancing antibacterial potency with biocompatibility?
- Could this scaffold be combined with growth factors for even faster wound healing?
Common questions
How does this wound dressing fight infection differently than antibiotics?
Why is the immune cell switch important for wound healing?
Read the original research
Hyaluronan Scaffold Decorated with Bifunctional Peptide Promotes Wound Healing via Antibacterial and Anti-Inflammatory.
Biomacromolecules, 25(12), 7850-7860
Citation
Wang, Yingzi; Zhao, Mingda; Zou, Yaping; Wang, Xiaojuan; Zhang, Min; Sun, Yong. (2024). Hyaluronan Scaffold Decorated with Bifunctional Peptide Promotes Wound Healing via Antibacterial and Anti-Inflammatory.. Biomacromolecules, 25(12), 7850-7860. https://doi.org/10.1021/acs.biomac.4c01130